Anna L. Godfrey

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Genomic Evolution of Myeloproliferative Neoplasms and Therapy-Associated Mutagenesis.

Genomic Evolution of Myeloproliferative Neoplasms and Therapy-Associated Mutagenesis.

Journal: Cancer discovery
Published: February 26, 2026

Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.

Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.

Journal: British journal of haematology
Published: February 25, 2026

Somatic and germline genetic testing pathways in haematological malignancies: Best practice consensus guidelines from the 2025 national meeting organised by UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.

Somatic and germline genetic testing pathways in haematological malignancies: Best practice consensus guidelines from the 2025 national meeting organised by UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.

Journal: British journal of haematology
Published: November 14, 2025

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Journal: Leukemia
Published: November 06, 2025

Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndrome.

Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndrome.

Journal: The Journal of clinical endocrinology and metabolism
Published: October 28, 2025

Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline.

Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline.

Journal: British journal of haematology
Published: September 15, 2025

Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis.

Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis.

Journal: Nature genetics
Published: June 09, 2024

Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice.

Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice.

Journal: British journal of haematology
Published: April 19, 2024

Changes in practice within a haematological malignancy diagnostic service: A 5-year retrospective study.

Changes in practice within a haematological malignancy diagnostic service: A 5-year retrospective study.

Journal: British journal of haematology
Published: April 01, 2024

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Journal: Blood
Published: August 25, 2023

The management of myelofibrosis: A British Society for Haematology Guideline.

The management of myelofibrosis: A British Society for Haematology Guideline.

Journal: British journal of haematology
Published: August 15, 2023

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.

Journal: British journal of haematology
Published: August 15, 2023
Showing 1-12 of 62

Last Updated: 09/26/2026